Blog

Shares of Arcus Biosciences, Inc. RCUS, a clinical-stage biopharmaceutical company, declined 14.4% following the announcement that its late-stage STAR-221 study was discontinued for futility.

The

An updated edition of the October 27, 2025 article.

Money is moving faster, smarter and increasingly without cash. Mobile payments are reshaping money flows across a connected global economy, with

IHS Holding (IHS) closed the last trading session at $7.35, gaining 17.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Paysign, Inc. (PAYS) closed the last trading session at $5.49, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of N-able (NABL) have gained 1.5% over the past four weeks to close the last trading session at $7.62, but there could still be a solid upside left in the stock if short-term price targets of

Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) closed the last trading session at $49.46, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if

Ooma (OOMA) closed the last trading session at $11.88, gaining 4.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Futu Holdings Limited Sponsored ADR (FUTU) closed the last trading session at $171.45, gaining 3.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term

Daktronics (DAKT) closed the last trading session at $18.77, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

BlackBerry Limited BB is set to report third-quarter fiscal 2026 results on Dec. 18.

The Zacks Consensus Estimate for the bottom line is pinned at 4 cents and has remained unchanged in the past 60

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Merck MRK announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) has rendered a positive opinion recommending approval of an expanded indication for

Pinterest, Inc. (PINS) has inked a definitive agreement to acquire tvScientific, a firm specializing in a connected TV (CTV) advertising platform. The buyout will enable Pinterest to bring its

Autonomous vehicle (AV) company WeRide Inc. WRD, and ride-hailing giant Uber Technologies, Inc. UBER have partnered with Dubai’s Roads and Transport Authority (RTA), to launch robotaxi passenger

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research